FDA Approved: EXEMESTANE — Original Application (Cipla USA Inc.)

View source ↗

Summary

FDA approves Cipla USA Inc.'s generic Exemestane as an original ANDA approval (ANDA 210323).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)

Snippet

ORIG AP for EXEMESTANE (EXEMESTANE)